|
🐜
|
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
22 auth.
P. Brown,
P. Brown,
K. Ballman,
K. Ballman,
J. Cerhan,
S. K. Anderson,
X. Carrero,
A. Whitton,
J. Greenspoon,
I. Parney,
...
N. Laack,
J. Ashman,
J. Bahary,
C. Hadjipanayis,
J. Urbanic,
F. Barker,
E. Farace,
D. Khuntia,
C. Giannini,
J. Buckner,
E. Galanis,
D. Roberge
|
9 |
2017 |
9
🐜
|
|
🐜
|
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
30 auth.
P. Brown,
V. Gondi,
S. Pugh,
W. Tomé,
J. Wefel,
T. Armstrong,
J. Bovi,
C. Robinson,
A. Konski,
D. Khuntia,
D. Grosshans,
T. Benzinger,
D. Bruner,
M. Gilbert,
D. Roberge,
...
V. Kundapur,
K. Devisetty,
Sunjay A. Shah,
K. Usuki,
B. Anderson,
B. Stea,
H. Yoon,
Jing Li,
N. Laack,
T. Kruser,
S. Chmura,
W. Shi,
S. Deshmukh,
M. Mehta,
L. Kachnic
|
9 |
2020 |
9
🐜
|
|
🐜
|
Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
17 auth.
J. Sarkaria,
Leland S. Hu,
I. Parney,
D. Pafundi,
D. Brinkmann,
N. Laack,
C. Giannini,
T. Burns,
S. Kizilbash,
Janice K. Laramy,
...
K. Swanson,
T. Kaufmann,
P. Brown,
N. Agar,
E. Galanis,
J. Buckner,
W. Elmquist
|
8 |
2018 |
8
🐜
|
|
🐜
|
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
25 auth.
Henry Ford,
E. Bell,
Peixin Zhang,
B. Fisher,
D. Macdonald,
J. McElroy,
G. Lesser,
J. Fleming,
A. Chakraborty,
Ziyan Liu,
A. Becker,
D. Fabian,
K. Aldape,
L. Ashby,
M. Werner-Wasik,
...
E. Walker,
J. Bahary,
Y. Kwok,
H. Yu,
N. Laack,
C. Schultz,
H. Gray,
H. Robins,
M. Mehta,
A. Chakravarti
|
7 |
2018 |
7
🐜
|
|
🐜
|
The role of LAT1 in 18F-DOPA uptake in malignant gliomas
12 auth.
R. Youland,
G. Kitange,
T. Peterson,
D. Pafundi,
J. Ramiscal,
J. Pokorny,
...
C. Giannini,
N. Laack,
I. Parney,
V. Lowe,
D. Brinkmann,
J. Sarkaria
|
7 |
2012 |
7
🐜
|
|
🐜
|
Stereotactic Body Radiotherapy in the Treatment of Adrenal Metastases
9 auth.
K. Ahmed,
B. Barney,
O. Macdonald,
Robert C. Miller,
Y. Garces,
N. Laack,
...
M. Haddock,
R. Foote,
K. Olivier
|
6 |
2013 |
6
🐜
|
|
🐜
|
Management of diffuse low-grade gliomas in adults — use of molecular diagnostics
7 auth.
J. Buckner,
C. Giannini,
J. Eckel-Passow,
D. Lachance,
I. Parney,
N. Laack,
...
R. Jenkins
|
6 |
2017 |
6
🐜
|
|
🐢
|
Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years.
8 auth.
R. Youland,
D. Schomas,
P. Brown,
C. Nwachukwu,
J. Buckner,
C. Giannini,
...
I. Parney,
N. Laack
|
5 |
2013 |
5
🐢
|
|
🐜
|
Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
11 auth.
M. Abdulaziz,
Grant W. Mallory,
M. Bydon,
Rafael de la Garza Ramos,
Jason A. Ellis,
N. Laack,
...
W. R. Marsh,
W. Krauss,
G. Jallo,
Z. Gokaslan,
Michelle J. Clarke
|
5 |
2015 |
5
🐜
|
|
🐢
|
Symptom management in premenopausal patients with breast cancer.
C. Loprinzi,
S. Wolf,
D. Barton,
N. Laack
|
5 |
2008 |
5
🐢
|
|
🐜
|
Preoperative Stereotactic Radiosurgery for Brain Metastases
11 auth.
D. Routman,
E. Yan,
S. Vora,
J. Peterson,
A. Mahajan,
K. Chaichana,
...
N. Laack,
P. Brown,
I. Parney,
T. Burns,
D. Trifiletti
|
5 |
2018 |
5
🐜
|
